Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors, 2023, Zhang et al

Discussion in 'Long Covid research' started by EndME, Nov 4, 2023.

  1. EndME

    EndME Senior Member (Voting Rights)

    Messages:
    1,094
    Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors

    Background
    As a debilitating condition that can impact a whole spectrum of people and involve multi-organ systems, long COVID has aroused the most attention than ever. However, mechanisms of long COVID are not clearly understood, and underlying biomarkers that can affect the long-term consequences of COVID-19 are paramount to be identified.

    Methods

    Participants for the current study were from a cohort study of COVID-19 survivors discharged from hospital between Jan 7, and May 29, 2020. We profiled the proteomic of plasma samples from hospitalised COVID-19 survivors at 6-month, 1-year, and 2-year after symptom onset and age and sex matched healthy controls. Fold-change of >2 or <0.5, and false-discovery rate adjusted P value of 0.05 were used to filter differentially expressed proteins (DEPs). In-genuity pathway analysis was performed to explore the down-stream effects in the dataset of significantly up- or down-regulated proteins. Proteins were integrated with long-term consequences of COVID-19 survivors to explore potential biomarkers of long COVID.

    Findings

    The proteomic of 709 plasma samples from 181 COVID-19 survivors and 181 matched healthy controls was profiled. In both COVID-19 and control group, 114 (63%) were male. The results indicated four major recovery modes of biological processes. Pathways related to cell–matrix interactions and cytoskeletal remodeling and hypertrophic cardiomyopathy and dilated cardiomyopathy pathways recovered relatively earlier which was before 1-year after infection. Majority of immune response pathways, complement and coagulation cascade, and cholesterol metabolism returned to similar status of matched healthy controls later but before 2-year after infection. Fc receptor signaling pathway still did not return to status similar to healthy controls at 2-year follow-up. Pathways related to neuron generation and differentiation showed persistent suppression across 2-year after infection. Among 98 DEPs from the above pathways, evidence was found for association of 11 proteins with lung function recovery, with the associations consistent at two consecutive or all three follow-ups. These proteins were mainly enriched in complement and coagulation (COMP, PLG, SERPINE1, SRGN, COL1A1, FLNA, and APOE) and hypertrophic/dilated cardiomyopathy (TPM2, TPM1, and AGT) pathways. Two DEPs (APOA4 and LRP1) involved in both neuron and cholesterol pathways showed associations with smell disorder.

    Interpretation

    The study findings provided molecular insights into potential mechanism of long COVID, and put forward biomarkers for more precise intervention to reduce burden of long COVID.

    https://www.thelancet.com/journals/...to our longitudinal cohort,to that at 6-month.
     
    SNT Gatchaman, Hutan, Mij and 2 others like this.
  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    27,997
    Location:
    Aotearoa New Zealand
    What's going on at the Lancet? Going by the abstract, the editing service is pretty bad. e.g. the first sentence
    It's a hospitalised cohort which isn't great for singling out the sort of Long Covid that we are most interested in. With the range of post-Covid impacts in this population and the relatively small sample size, there's going to be a lot of noise to signal and multiple signals. In the abstract, they don't actually say how many of the 181 hospitalised Covid-19 survivors had persisting symptoms at 2 years.
     
    alktipping and EndME like this.

Share This Page